CTA101 cell injection in the treatment of patients with recurrent or refractory B-type hematologic malignancies

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
This article has no abstract
Epistemonikos ID: 34f2ebbac5ac3c3252f0e310bab9215d8f6a4345
First added on: Apr 07, 2025